论文部分内容阅读
多数小细胞肺癌(SCLC)确诊后仅适于化疗。改善这类病人预后的先决条件也是联合化疗。本文报道一组近期确诊的 SCLC,用 CCE 方案再用 VDP 方案的疗效观察。经病理证实的 SCLC 患者70例。既往未接受任何化疗和放疗。用两个三周疗程的 CCE 方案(第1天用环磷酰胺(CTX)750mg/m~2 Ⅳ,顺氯氨铂(PDD)75mg/m~2 Ⅳ,第2、5、8天用 Vp16 100mg/m~2 Ⅳ)。再用两个三周疗程的 VDP 方案,在第50天和第71天开
Most patients with small cell lung cancer (SCLC) are only eligible for chemotherapy after diagnosis. The prerequisite for improving the prognosis of these patients is also combined with chemotherapy. This article reports on a group of recently diagnosed SCLCs, using the CCE regimen to observe the efficacy of the VDP regimen. 70 cases of pathologically confirmed SCLC patients. Never received any chemotherapy or radiotherapy. Two three-week course of CCE regimens (CTX 750 mg/m~2 IV on Day 1 and 75 mg/m~2 IV of cisplatin (PDD), Vp16 on Day 2, 5, and 8 100mg/m~2 IV). Then use two three-week courses of VDP to open on the 50th and 71st days.